ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
다우존스 지수
40,003.59
0.34%
Bitcoin
66,883.90
-0.29%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE
  6. Hemogenyx Pharmaceuticals Plc (HEMO)

  7. Hemogenyx Pharmaceuticals Plc (HEMO) 뉴스

HEMO

Hemogenyx Pharmaceuticals (HEMO)

Hemogenyx Pharmaceuticals Plc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:HEMO
일자시간출처헤드라인심볼기업
2024/04/2520:19Alliance NewsAlliance NewsEARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payoutLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/04/2515:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Final ResultsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/03/2816:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/2923:04Alliance NewsAlliance NewsHemogenyx Pharmaceuticals raises money for leukaemia treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/2916:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Placing to Raise US$4.2 millionLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1620:27Alliance NewsAlliance NewsHemogenyx shares rise on potential for CBR to treat brain diseasesLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1616:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Brain DeliveryLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1419:14Alliance NewsAlliance NewsHemogenyx says CBR can be used intranasally to treat viral infectionsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1416:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Intranasal DeliveryLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0919:00Alliance NewsAlliance NewsIN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial holdLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0916:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC FDA Consents to Phase I Trials of HEMO-CAR-TLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0219:44Alliance NewsAlliance NewsIN BRIEF: Hemogenyx hails US patent application progressLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0216:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Approval and Issuance of U.S. Conditioning PatentLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/01/1620:13Alliance NewsAlliance NewsHemogenyx Pharmaceuticals sends complete response on HEMO-CAR-T to FDALSE:HEMOHemogenyx Pharmaceuticals Plc
2024/01/1616:00UK RegulatoryHemogenyx Pharmaceuticals PLC Submission of Complete Response to Clinical HoldLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/01/0819:56Alliance NewsAlliance NewsHemogenyx Pharmaceuticals completes process qualification runLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/01/0816:00UK RegulatoryHemogenyx Pharmaceuticals PLC HEMO-CAR-T Process Qualification Run CompletedLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/11/2901:53Alliance NewsAlliance NewsTRADING UPDATES: Upland Resources completes technical study at SarawakLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/11/2821:19UK RegulatoryHemogenyx Pharmaceuticals PLC Placing to Raise GBP534,375LSE:HEMOHemogenyx Pharmaceuticals Plc
2023/11/2719:52Alliance NewsAlliance NewsHemogenyx shares up as says CBR platform a potential cancer treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/11/2716:00UK RegulatoryHemogenyx Pharmaceuticals PLC CBR Expanded to Treatment of CancerLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/11/1600:43Alliance NewsAlliance NewsHemogenyx Pharmaceuticals completes lentivirus re-manufactureLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/11/1516:00UK RegulatoryHemogenyx Pharmaceuticals PLC Lentivirus Re-manufacturing CompletedLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/10/3116:00UK RegulatoryHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/09/2822:24Alliance NewsAlliance NewsEARNINGS: Dar Global profit multiplies, Hemogenyx loss widensLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/09/2820:28UK RegulatoryHemogenyx Pharmaceuticals PLC Half-year ReportLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/09/1822:37Alliance NewsAlliance NewsTRADING UPDATES: Avingtrans buys Adaptix, TPXimpact sells QuestersLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/09/1815:00UK RegulatoryHemogenyx Pharmaceuticals PLC Strategic Investment from Prevail Partners, LLCLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/09/1422:31Alliance NewsAlliance NewsHemogenyx Pharma says US FDA accepts Hemo-Car-T clinical hold lift planLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/09/1417:11Dow Jones NewsHemogenyx Pharmaceuticals Says FDA Accepted Plans to Address Leukemia Treatment ConcernsLSE:HEMOHemogenyx Pharmaceuticals Plc
 검색 관련기사 보기:LSE:HEMO

최근 히스토리

NYSE
CBL-D
CBL and Associates Prope...
NYSE
IEL
LSE
SE17
Nationwde.27 A
COIN
SFCCUST
SafeCap Token
ASX
CE1DB
Calima Energy
KOSPI
091810
티웨이항공
AMEX
VEU
Vanguard FTSE All World ...
LSE
VDS
Vividas
BIT
DIT
Destination Italia
BIT
F12477
Vontobel Financial Produ...
COIN
CMTCEUR
NASDAQ
SNCY
Sun Country Airlines
NYSE
COF-P.CL
Capital One Financial
COIN
ETHDETH
CXIO
XLMUSDT
Stellar Lumens
TSXV
MOO
Moon River Moly
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유